EUVIMEDEUVIMED entdecken
Editorial

IRF1 is a master regulator of type 1 eosinophils

Immaculeta Osuji, Nives Zimmermann

Journal of Allergy and Clinical Immunology · 2026-05 · 157 (5) · 1031-1033

DOI: 10.1016/j.jaci.2026.02.042 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-05. Verfasst von Immaculeta Osuji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Physiology, and Neurobiology, University of Cincinnati College of Medicine, Cincinnati, Ohio. Die Arbeit nennt 10 Literaturangaben. Gefördert von: National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Eosinophilactivation stateinflammationtranscriptional regulation

Autor:innen und Institutionen

  • Department of Pharmacology, Physiology, and Neurobiology, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Allergy and Immunology, Cincinnati Children's Hospital, Cincinnati, Ohio. Electronic address:…

Förderung

  • National Heart Lung and Blood Institute

Zitieren

APA

Osuji, I., & Zimmermann, N. (2026). IRF1 is a master regulator of type 1 eosinophils. Journal of Allergy and Clinical Immunology, 157(5), 1031-1033. https://doi.org/10.1016/j.jaci.2026.02.042

Vancouver

Osuji I, Zimmermann N. IRF1 is a master regulator of type 1 eosinophils. Journal of Allergy and Clinical Immunology. 2026;157(5):1031-1033. doi:10.1016/j.jaci.2026.02.042

BibTeX
@article{Osuji2026,
  author = {Osuji, Immaculeta and Zimmermann, Nives},
  title = {IRF1 is a master regulator of type 1 eosinophils},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  volume = {157},
  number = {5},
  pages = {1031--1033},
  doi = {10.1016/j.jaci.2026.02.042}
}
Kostenlos starten →